Shinohara T, Taura K i, Imamura T, Yamada H, Oguri K
Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Drug Metab Dispos. 1997 Dec;25(12):1442-6.
To study the specific target to which phenobarbital (PB) binds, resulting in the induction of cytochrome P450, we prepared two azido-PBs (AZPBs) as photoaffinity ligands. The azido substituent was introduced at the para- or meta-position of the PB aromatic ring. In this study, we estimated the utility of these compounds by examining their inducing activities in vivo in rats. Induction was assessed by immunoblotting with anti-CYP2B1/2 antibody and measuring testosterone-metabolizing activity, using hepatic microsomes. Administration of p-AZPB to rats increased hepatic CYP2B1/2 protein and testosterone 16beta-hydroxylase activity, although the effects were less than those of unmodified PB. m-AZPB showed no effect in the induction of CYP2B1/2. To assess the specificity of the effects of substituents, we compared the inducing activities of p/m-nitro-PBs, p/m-amino-PBs, and p/m-hydroxy-PBs with those of AZPBs. The results showed that p-nitro-PB, m-amino-PB, and p-hydroxy-PB were also potent inducers for CYP2B1/2, with lower activity than that of unmodified PB, whereas the other three isomers had no effect. These results suggest that 1) the absence of any substituents on the aromatic ring of PB is needed for maximal inducing activity and 2) substitution at the meta-position of the PB aromatic ring tends to reduce effectiveness as an inducer more than does substitution at the para-position. Because p-amino-PB and p-acetylamino-PB, the minor and major metabolites of p-AZPB, respectively, were without effect in the induction of CYP2B1/2, the effect of p-AZPB was considered to be due to the unchanged compound itself. The present study demonstrates that, based on the weak but positive ability to induce CYP2B1/2, p-AZPB may be a useful tool for identifying the putative PB receptor.
为了研究苯巴比妥(PB)结合导致细胞色素P450诱导的特定靶点,我们制备了两种叠氮基苯巴比妥(AZPBs)作为光亲和配体。叠氮基取代基被引入到PB芳香环的对位或间位。在本研究中,我们通过检测这些化合物在大鼠体内的诱导活性来评估其效用。通过用抗CYP2B1/2抗体进行免疫印迹并使用肝微粒体测量睾酮代谢活性来评估诱导情况。给大鼠施用对叠氮基苯巴比妥(p - AZPB)可增加肝脏CYP2B1/2蛋白和睾酮16β - 羟化酶活性,尽管其效果低于未修饰的PB。间叠氮基苯巴比妥(m - AZPB)在诱导CYP2B1/2方面无作用。为了评估取代基效应的特异性,我们比较了对/间硝基苯巴比妥、对/间氨基苯巴比妥和对/间羟基苯巴比妥与AZPBs的诱导活性。结果表明,对硝基苯巴比妥、间氨基苯巴比妥和对羟基苯巴比妥也是CYP2B1/2的有效诱导剂,其活性低于未修饰的PB,而其他三种异构体无作用。这些结果表明:1)PB芳香环上无任何取代基对于最大诱导活性是必需的;2)PB芳香环间位的取代比对位取代更倾向于降低作为诱导剂的有效性。由于对叠氮基苯巴比妥的次要和主要代谢产物分别为对氨基苯巴比妥和对乙酰氨基苯巴比妥,它们在诱导CYP2B1/2方面无作用,因此认为对叠氮基苯巴比妥的作用归因于未改变的化合物本身。本研究表明,基于诱导CYP2B1/2的微弱但积极的能力,对叠氮基苯巴比妥可能是鉴定假定的PB受体的有用工具。